Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

Conditions:   Latent Tuberculosis;   Diabetes Mellitus, Type 2 Interventions:   Drug: Rifampicin 300 Mg Oral Capsule;   Drug: Isoniazid 300 MG Sponsor:   Herlev and Gentofte Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials